Capricor Therapeutics (CAPR) Receivables - Other (2012 - 2025)

Capricor Therapeutics' Receivables - Other history runs 13 years deep, the most recent figure standing at $59167.0 for Q4 2025.

• In Q4 2025, Receivables - Other fell 99.43% year-over-year to $59167.0; the TTM figure through Dec 2025 stood at $59167.0 (down 99.43% YoY), while the FY2024 annual figure was $10.0 million, changed 0.0% from the prior year.
• Receivables - Other was $59167.0 for Q4 2025 at Capricor Therapeutics, down from $59509.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $10.4 million in Q4 2024 to a low of $59167.0 in Q4 2025.
• Historically, Receivables - Other has averaged $1.4 million across 5 years, with a median of $409682.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Receivables - Other soared 1726.22% in 2023, then sank 99.43% in 2025.
• A 5-year view of Receivables - Other shows it stood at $391750.0 in 2021, then soared by 39.78% to $547580.0 in 2022, then jumped by 1726.22% to $10.0 million in 2023, then grew by 3.68% to $10.4 million in 2024, then tumbled by 99.43% to $59167.0 in 2025.
• The last three Receivables - Other figures came in at $59167.0 (Q4 2025), $59509.0 (Q2 2025), and $59834.0 (Q1 2025), per Business Quant data.